Please login to the form below
pulmonary embolism
This page shows the latest pulmonary embolism news and features for those working in and with pharma, biotech and healthcare.
Zafgen shares tumble after FDA places hold on diabetes trial
This was abandoned in 2016 after two patients died in a phase 3 trial of the drug after suffering a pulmonary embolism.
Latest news
-
Boston Scientific makes $4.2bn play for UK’s BTG
Boston Scientific’s chief executive Michael Mahoney highlighted BTG’s cancer and pulmonary embolism portfolios – which include products to freeze and deliver radiotherapy or drugs to tumours and devices to dissolve
-
AbbVie builds case for arthritis blockbuster-in-waiting upadacitinib
as pulmonary embolism (PE) or deep vein thrombosis (DVT) and an uncompetitive dose.
-
FDA panel undermines Lilly and Incyte’s baricitinib hopes
baricitinib’s potential to cause side effects such as pulmonary embolism and venous thromboembolism.
-
AbbVie’s JAK inhibitor upadacitinib clears another phase III trial
There was a fatality from a stroke in the trial in a patient, plus one case of a pulmonary embolism, although AbbVie said these occurred in at-risk patients.
-
Xarelto beats aspirin for recurrent blood clots
Janssen's parent company Johnson &Johnson (J&J) said in a statement that up to 10% of people who have suffered a VTE (usually a deep vein thrombosis or pulmonary embolism)
More from news
Approximately 2 fully matching, plus 46 partially matching documents found.
Latest Intelligence
-
Modern anticoagulants threaten status quo
embolism in patients with AF and for the prevention of VTE in patients undergoing knee or hip replacement surgery. ... In one phase III trial, idrabiotaparinux sodium was non-inferior to warfarin in preventing the recurrent VTE at three months in
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
- FREELANCE Medical Writer (Initial 2/ 3 months term) - London Off...
-
Excellent Daily Rate
- Account Director, Healthcare Communications
-
Salary TBC
- Account Director - Medical Communications - London / South East
-
Excellent Salary and Benefits on offer
- FREELANCE Account Director – Healthcare Advertising – London – 3...
-
Competitive Daily Rates
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
- Account Director – London based Medical Communications Agency
-
Excellent Remuneration Package
-
Account Director – UK Office
-
Excellent salary and benefits
Subscribe to our email news alerts
- The relevance of patient perspectives to value
- Sanofi patent case win holds off generic rivals for key cancer drug
- Leo Pharma to market AstraZeneca’s brodalumab outside Europe
- Regeneron scores positive data in phase 3 cholesterol trial
- Roche undercuts price of Bayer cancer drug after winning FDA approval
- Putting our core values into practice at the Porterhouse summer social
PMHub
W2O Group
W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...
Latest intelligence
- The relevance of patient perspectives to value
- Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
- How is the NHS Long-term Plan being put into action?
- Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
- The evolution of real-world studies
- How industry and regulators are using real-world data...
Quick links
Infographics
